XML 37 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Values
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Fair Values

14. FAIR VALUES

Assets and Liabilities Measured at Fair Value

The following table summarizes our assets and liabilities measured at fair value on a recurring basis ($ in thousands):

 

     September 30, 2016      December 31, 2015  
     Level 1      Level 2      Level 3      Fair Value      Level 1      Level 2      Level 3      Fair Value  

Assets

                       

Derivatives

   $ —         $ 268       $ —         $ 268       $ —         $   8,657       $ —         $ 8,657   

Other assets(1)

   $ —         $ 241       $   1,200       $   1,441       $ —         $ 1,659       $   12,561       $   14,220   

Liabilities

                       

Derivatives

   $ —         $ 1,141       $ —         $ 1,141       $ —         $ 1,448       $       $ 1,448   

 

(1)

Other assets include loans, securities, equity investments, and other receivables measured at fair value.

The following table reconciles the beginning and ending balances of assets measured at fair value on a recurring basis using Level 3 inputs ($ in thousands):

 

     Nine Months Ended September 30,  
     2016      2015  

January 1,

   $ 12,561       $ 47,507   

Proceeds from investment realizations

     (2,406      (57,039

Transfers out of level 3

     (20,745      —     

Adjustments to fair value included in earnings

     

Gain on investments at fair value

     11,790         22,228   
  

 

 

    

 

 

 

September 30,

   $ 1,200       $ 12,696   
  

 

 

    

 

 

 

During the second quarter of 2016, $20.7 million of collateralized debt obligations, or CDOs, were transferred out of Level 3 and into Level 1 as a result of a binding agreement to sell the underlying collateral assets of the CDO to an independent third-party. These investments were realized in the third quarter of 2016. Refer to Note 2 for further discussion regarding fair value measurement.

Fair Value of Financial Instruments

As discussed in Note 2, GAAP requires disclosure of fair value information about financial instruments, whether or not recognized in the statement of financial position, for which it is practicable to estimate that value. The following table details the carrying amount, face amount, and fair value of the financial instruments described in Note 2 ($ in thousands):

 

     September 30, 2016      December 31, 2015  
     Carrying      Face      Fair      Carrying      Face      Fair  
     Amount      Amount      Value      Amount      Amount      Value  

Financial assets

                 

Cash and cash equivalents

   $ 94,061       $ 94,061       $ 94,061       $ 96,450       $ 96,450       $ 96,450   

Restricted cash

     877         877         877         9,556         9,556         9,556   

Loans receivable, net

       8,347,712           8,381,679           8,392,677           9,077,007           9,108,361           9,121,732   

Financial liabilities

                 

Secured debt agreements

     5,320,358         5,335,908         5,335,908         6,116,105         6,131,751         6,131,751   

Loan participations sold

     409,654         411,427         411,427         497,032         498,992         498,992   

Convertible notes, net

     166,064         172,500         190,181         164,026         172,500         171,344   

Estimates of fair value for cash and cash equivalents, restricted cash and convertible notes are measured using observable, quoted market prices, or Level 1 inputs. All other fair value significant estimates are measured using unobservable inputs, or Level 3 inputs. See Note 2 for further discussion regarding fair value measurement of certain of our assets and liabilities.